Laboratories performing immunology testing are advised of changes to the available scope of accreditation.
The following amendments have been made:
| 10.40 | Immunology | |
| .26 | Tests of cellular immunity - lymphokine assays | |
| .30 | Assessment of neutrophils and monocytes - quantitation | |
| .32 | Assessment of neutrophils and monocytes - in vitro functional tests | |
| .40 | Tissue typing | |
| .41 | HLA B27 | |
Are now expressed as:
| 10.40 | Immunology | |
| .26 | Tests of cellular immunity - cytokine assays | |
| .30 | Assessment of neutrophils - quantitation | |
| .32 | Assessment of neutrophils - in vitro functional tests | |
| .40 | Human Leucocyte Antigen (HLA) typing | |
| .41 | HLA Single Antigen Tests Descriptor required: HLA - B27, HLA B51 | |
Laboratories accredited to these subclasses are advised that the editorial changes have already been applied to their scope of accreditation. Laboratories may obtain a copy of their current scope of accreditation at the NATA website (www.nata.com.au).
The following subclasses have been deleted:
| 10.40 | Immunology | |
| .52 | Allergen - specific IgG | |
| .55 | Detection of immune complexes in body fluids and biopsy material | |
Laboratories whose current scope of accreditation includes these subclasses will be formally advised of these deletions in their next report on reassessment.
If you have any further questions, please do not hesitate to contact Andrew Griffin, Deputy Field Manager, Medical Testing (02) 9736 8222.
